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Dehydroalanine (Dha) and dehydrobutyrine (Dhb) display considerable flexibility in a variety 
of chemical and biological reactions. Natural products containing Dha and/or Dhb residues are 
often found to possess diverse biological activities. While the (Z)-geometry is predominant in 
nature, only a handful of metabolites containing (E)-Dhb have been found thus far. Here we 
report discovery of a new antimicrobial peptide, albopeptide, through NMR analysis and 
chemical synthesis, which contains two contiguous unsaturated residues, Dha-(E)-Dhb. It 
displays narrow-spectrum activity against vancomycin-resistant Enterococcus faecium. In vitro 
biochemical assays show that albopeptide originates from a noncanonical NRPS pathway, 
featured with dehydration processes, catalysed by unusual condensation domains. Finally, we 
provide evidence of the occurrence of a previously untapped group of short unsaturated 
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Timing of dehydration: Albopeptide, a new antibacterial short peptidyl metabolite, was found 
to contain a unique contiguous Dha-(E)-Dhb moiety. In vitro reconstitution and biochemical 
analysis together with chemical capture of online biosynthetic intermediates demonstrated that 
two condensation domains in the corresponding NRPSs catalyse the dehydration reactions 
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Dehydroalanine (Dha) and dehydrobutyrine (Dhb) are noncanonical amino acids found in in a 
wide array of natural products (NPs) from various organisms, many of which display 
antibacterial, antifungal, antitumor and phytotoxic activity[1]. Both Dha and Dhb have profound 
effects on the properties of the molecule. They display significant synthetic flexibility, readily 
undergoing reactions such as Michael additions, transition-metal-catalysed cross-couplings, 
and cycloadditions. They are also used as orthogonal chemical handles for later stage 
modification of biomolecules[2].  
Dha is the simplest dehydroamino acid (dhAA) without geometrical isomers while Dhb is the 
simplest dhAA displaying E/Z isomerism. The Z isomer of Dhb is sterically favourable [3] and 
is present in a majority of NPs containing the Dhb residue. Dha and (Z)-Dhb motifs are 
commonly found in ribosomally synthesized and post-translationally modified peptides 
(RiPPs). Dha and Dhb motifs in RiPPs are generated from Ser/Cys and Thr residues, 
respectively, via  in trans activation, followed by elimination with anti stereoselectivity (in the 
case of L-Thr) by dedicated biosynthetic enzymes[4].  
Although less common, Dha and Dhb motifs do appear in non-ribosomal peptides (NRPs). For 
example, they are present in the cyclic pentadepsipeptide, phomalide 1[5], the 
cycloheptapeptide, [D-Asp3, (Z)-Dhb7] microcystin 2[6], the β-lactam antibiotic norcardicin 3[7], 
the pyrrolizidine alkaloid azabicyclene 4[8] and the nonproteinogenic amino acid 
methoxyvinylglycine 5[9] (Figure 1A). In contrast to RiPPs, both (Z)- and (E) -Dhb geometries 
have been found in NRPs. A typical example is microcystins (MCs), the most widespread class 
of cyanotoxins discovered in cyanobacteria. The majority of MCs consists of N-methyl-Dha 
residue at position 7[6]. Around 30 MC congeners were found to contain the Dhb moiety, among 
which only two have been characterized by NMR structural elucidation to be (Z)-Dhb residues, 
including MC congener 2 discovered from an environmental Oscillatoria agardhii isolate [10]. 
Ten of MC congeners consist of (E)-Dhb moiety [6], for example, the isomer of 2 containing E-
Dhb motif was isolated from O. agardhii CCAP1459/14[11]. It is worth to note that the geometry 
of Dhb residue in some of these NPs is crucial for their biological activity[13,14]. An interesting 
example can be found in phomalide 1 (Figure 1A) and its synthetic isomer, isophomalide[13]. 
Phomalide 1 is a selective phytotoxin, causing leaf spot and stem cankers (blackleg)[5], while 
its isomer, isophomalide, is not a causative agent[13].  
Recent biochemical studies indicated that one of the condensation domains (NocB-M5C) in 
the pathway of nocardicin 3 catalyses the dehydration of a seryl-containing tetrapeptidyl 
thioester to generate a transient Dha-containing intermediate for subsequent cyclization to 
afford the β-lactam ring system[6,11]. This C domain consists of the H(790)HHxxxDG catalytic 
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residue (H790) was proposed to catalyse the β-elimination to generate cryptic Dha-containing 
intermediate[14]. In vitro biosynthetic reconstitution of two NRPS-derived metabolites, 
azabicyclene 4 and methoxyvinylglycine 5, also suggested that two noncanonical C* domains 
are likely to be responsible for the formation of cryptic Dha and cis-α,β dehydroglumate 
intermediates, respectively, in the corresponding NRPS pathways[8,9]. However, the formation 
of Dhb residues in NRPs remains to be determined. This is the particular case for (E)-Dhb 
residues. Unlike (Z)-Dhb, the bio-origin of (E)-Dhb is less obvious. It has raised a question of 
whether (E)-Dhb residues in NRPs are derived from L-allo-Thr [12] via facile anti-elimination or 
they directly descend from syn-elimination in which two vicinal substituents (e.g. α-H and β-
hydroxide) on the L-Thr residue leave simultaneously, an analogous process of chemical 
precedent under elevated temperatures and harsh conditions[3].  
 
Herein, we report the identification of a new short linear peptide, albopeptide 6, from the soil 
bacterium Streptomyces albofaciens (NCIMB 10975) (Figure 1B). The complete structure of 
 
Figure 1. A. structural examples of NRPs containing residues derived from dhAAs 
(highlighted in red); B. Structure of the new short peptide, albopeptide 6, isolated from 
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6 was determined to be L-valyl-Dha-(E)-Dhb through comprehensive NMR, high-resolution 
MS analyses and chemical synthesis together with NMR spectral comparisons of natural 6 
with synthetic 6 and its Z-isomer 6a. To the best of our knowledge, the contiguous Dha-(E)Dhb 
combination is unique in NPs. Bioinformatics and in vitro reconstitution showed that only two 
multidomain non-ribosomal peptide synthetases AlbA and AlbB are required for the production 
of albopeptide 6. Our detailed biochemical analysis not only demonstrated the timing of the 
dehydration events during the 6 biosynthesis but also confirmed that two unusual C* domains, 
AlbB-C2 and -C3, catalyse the dehydration to generate Dha and (E)-Dhb residues, respectively. 
Comparative genomic analysis revealed the occurrence of similar biosynthetic gene clusters 
(BGCs) in Gram-negative and Gram-positive bacteria that potentially produce a previously 
unnoticed group of short dehydrated NRPs. Albopeptide 6 displays a potent narrow-spectrum 
antibacterial activity against a vancomycin-resistant Enterococcus faecium hospital isolate 
with a MIC of 2.98±0.07 µM. 
2 Results 
2.1 Discovery of a new short peptide 6  
Over the course of efforts toward the search of new natural antimicrobial metabolites, we 
investigated metabolic profiles of S. albofaciens using liquid chromatography coupled to high 
resolution electrospray ionization mass spectroscopy (HR-ESIMS) analysis. The MS data 
were examined by molecular network analysis[15]. The crude extract generated from the 
Modified Bennett's medium was identified to contain structurally diverse classes of metabolites 
(Figure S1-4, Table S1). In addition, clusters of compounds having low (<300 Da) mass-to-
charge ratios (m/z) were identified in the network. The absence of these observed masses in 
NP databases[16],[17] suggested the presence of new metabolites. 
Subsequent large-scale fermentation (12L), followed by chemical workup, afforded the 
isolation of compound 6 (0.6 mg). The molecular formula of 6 (Figure 1) was established as 
C12H20O4N3+ by HR-ESIMS (obsd. [M+H]+ = 270.1449; calcd. [M+H]+ = 270.1448; ∆ = 0.37 
ppm), with five degrees of unsaturation. The planar structure of 6 was deduced to be Val-Dha-
Dhb by HR-ESIMS, 1D and 2D NMR analyses (Figure S2-7, Table S2).  
Advanced Marfey’s analysis confirmed that 6 contains L-valine (Figure S8). The determination 
of the geometry of Dhb moiety in 6 was based on the interpretation of 1H NMR and 1H-1H 
NOESY spectra in DMSO-d6 (Figure S6). The olefinic proton in Dhb unit of 6 appears at 6.03 
ppm, and displays a, albeit weak, correlation with 5’-H at the amide moiety, suggesting that 
the geometry of the Dhb unit in 6 is E. The absence of any (Z)-Dhb containing 6 isomer during 
the chemical workup and structural elucidation indicated that the isolated 6 is a pure E 
configurational isomer. 
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Finally support for the proposed structure of 6 was provided by the total synthesis of isomers 
6 and 6a, containing the E and Z configurations of the Dhb motifs, respectively (Figure 2). L-
Thr was converted into its allyl ester and coupled with Boc-protected Ser to yield the dipeptide 
7. This peptide was further coupled with Boc-protected valine to give the Boc-L-Val-L-Ser-L-
Thr allyl ester 8. Subsequent elimination of the hydroxy groups of the Ser and Thr residues 
was performed by treatment with 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC) and 
copper (II) chloride to generate the desired Dha and Dhb residues[18]. Another portion of 8 was 
treated with mesyl chloride and triethylamine to give 6a, containing the (Z)-Dhb unit (100% 
ee)[3]. Finally, removal of the allyl and Boc groups using conventional reaction conditions 
afforded a mixture of 6 and 6a containing the E/Z configured-Dhb motif (approx. 50:50) in the 
first case, and pure isomer 6a containing the Z-configured Dhb unit in the second. Attempts to 
synthesize the pure E-isomer from the ester 8 was unsuccessful. It is well known that the 
thermodynamic instability of an (E)-Dhb residue in comparison to its (Z) counterpart makes its 
stereoselective construction highly challenging. [18,19] In general, the 1, 3-allylic strain of the 
(E)-Dhb residue is higher than that of the (Z) derivative due to steric interactions in (E)-Dhb. 
This led to generation of a mixture containing the thermodynamically stable Z-6a under the 
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Dhb residue in the synthesis of vioprolides[18]. Nonetheless, the E/Z isomeric mixture of 6 and 
6a provided the required information on the olefin geometry of isolated peptide 6. 
2.3 NMR spectral comparison among natural 6 and synthetic isomers  
With the synthetic isomers 6 and 6a available, we carried out detailed analyses and 
comparisons of the 1H-NMR spectra in CD3OD (Table S2, Figure 3) of the natural peptide 6 
with the synthetic peptides 6 and 6a. The natural compound 6 had identical proton chemical 
shifts to the synthetic one containing the E-Dhb motif (δH 6.46 and 2.09 (Hβ and CH3 in Dhb, 
respectively) which are clearly different to the ones containing the Z-Dhb motif (δH 6.98 and 
1.8, respectively) (Figure 3). This confirmed that the Dhb residue in natural 6 has indeed the 
E configuration. 
 
Figure 2. Synthesis route of E/Z albopeptide 6, 6a. Reagents and conditions: i, allyl alcohol, 
p-toluenesulfonic acid, 16 h, 110 °C; ii, Boc-L-Ser, PyBoP, HOBt, DIPEA, 22 h, RT, 56.1%; 
iii, TFA (quant.); iv, Boc-L-Val, PyBoP, HOBt, DIPEA, 22 h, RT, 39.4%; v, EDC 2eq. CuCl2 
0.2eq, anhydrous toluene 80 °C , 2 h, argon, 20% (50.0%); vi, Pd(PPh3)4, PhSiH3, DCM, 2 
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Another interesting observation in this NMR comparison is the chemical shifts of Dha residues 
in these two isomers. The geometry of the double bond of Dhb in these contiguous Dha-Dhb 
residues strongly influences the chemical shifts of two olefinic protons in the adjacent Dha 
residue in 6, which appear upfield, compared to the respective signals in 6a that contains a 
(Z)-Dhb moiety (Figure 3).  
Taken together, our experimental data demonstrated that compound 6 is a new short peptide 
metabolite, which we named albopeptide, by association with the strain name. 
2.4 Biological Tests  
Due to the availability of sub-milligram quantities of natural albopeptide, the synthetic materials 
6/6a (50:50) and 6a, were used to investigate their biological properties against a panel of 
standard bacterial pathogens and clinical isolates of bacterial pathogens (Materials and 
Methods). The peptide mixture 6/6a displayed no significant activities against most of bacterial 
pathogens tested except for the clinical isolate vancomycin-resistant Enterococcus faecium 
K60-39[20] with a potent MIC value of 2.98±0.07 µM (Figure S24). Interestingly, Z-peptide 6a 
showed no activity against E. faecium K60-39, indicating that albopeptide 6 is solely 
responsible for the observed antibiotic activity. Further analysis of the mode of action of 6 
would be of considerable interest. 
 
Figure 3. 1H-NMR spectral comparison of natural compound 6, synthetic Z-isomer 6a, and 
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2.5 Identification of the biosynthetic gene cluster of 6 
Molecular network analysis (Figure S1, Table S1) indicated that albopeptide 6 is only 
associated with one ion, suggesting that 6 may not be originated from ribosomally synthesized 
and post-translationally modified peptides (RiPPs), which normally have large molecular 
weights (>500 Da)[21]. This prompted us to investigate whether 6 may originate from a NRPS 
assembly. In silico analysis of the annotated draft genome (NCBI accession: 
NZ_PDCM01000002.1) allowed identification of the putative biosynthetic gene cluster (alb 
BGC) (Figure 4A). The centre of the alb BGC encodes two multidomain NRPSs (AlbA and 
AlbB), both of which possess arrangements of A1-T1-C1 and A2-T2-C2-A3-T3-C3-T4, respectively 
(Figure 4A). The A domains of AlbA and AlbB were predicted to activate Val, Ser and Thr [22], 
respectively, which is consistent with the predicted precursors. No gene/domain encoding 
thioesterase was found within the NRPS gene or in the close proximity of the alb BGC, 
suggesting an unusual release mechanism of thiolate-template peptidyl intermediate 
generated by NRPS.  
Although only two peptide bonds are present in 6, three condensation domains were observed, 
suggesting that some of these C domains may be involved in unconventional processes. 
Phylogenetic analysis of C domains[23] revealed that, while AlbA-C1 is a normal L-amino acid 
condensation domain, AlbB-C2 and C3 belong to a unique group of C* domains which are also 
found in the biosynthetic pathways of NPs, such as methoxyvinylglycine[9], legonmycin[24], 
azabicyclene[8], puwainaphycin[25], FK228[26], bleomycin[27], hassallidin[28], nodularin[29] and 
microcystin[30] (Figure 4B). All of these NPs contain either dhAA motifs or motifs derived from 
dhAA residues. 
2.6 In vitro pathway reconstitution and biochemical analysis. 
To confirm the identity of these NRPSs, we set out to investigate the roles of both AlbA and 
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(DE3)-RP allowed for the purification of the corresponding recombinant proteins to near 
homogeneity, respectively (Figure S25).  
We first sought to reconstitute the biosynthesis of 6 in vitro. To this end, we performed a one-
pot bioassay. AlbA and AlbB were first converted into their holo form by the 
phosphopantetheine (Ppant) transferase Sfp in the presence of Coenzyme A (CoA) and MgCl2, 
followed by incubation with substrates Val, Ser and Thr and ATP. This assay yielded a product, 
which has the same retention time as the standard 6 as observed in HPLC analysis (Figure 
4C). The corresponding ion is also identical to 6 based on LC-HR-MS and tandem MS 
analyses (Figure S26-27). Omission of each substrate, or each individual enzyme abolished 
the formation of 6 (Figure S26), confirming that each enzyme and substrate is necessary for 
the biosynthesis of 6. It is worth to note that using L-allo-Thr to replace L-Thr in the above 
biotransformation resulted in no production of 6, indicating that (E)-Dhb moiety in 6 is not 
derived from L-allo-Thr.  
 
Figure 4. A. The arrangement of the alb gene cluster responsible for the biosynthesis of 6. 
B. Phylogenetic analysis of C* domains in AlbB with C* domains identified in other 
biosynthetic pathways, suggesting that C2 and C3 domains belong to a unique group of C 
domains in bacteria. LCL: condensation between two L amino acids; DCL: condensation 
between a D- and a L-amino acid; Starter: acylation of the first amino acid with a β-hydroxy-
carboxylic acid; Cy: cyclization; E: epimerization; Dual: epimerization and condensation. C. 
HPLC analysis for in vitro reconstitution catalysed by AlbA and AlbB, demonstrating that 
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We next set out to investigate the dehydration events of the Ser and Thr residues during the 
biotransformation. In this case, we attempted a chemical derivatization strategy to capture the 
biosynthetic intermediate attached to the full length NRPSs, which involves the use of 
cysteamine as a thioester reactive probe[9]. Incubation of AlbA or/and AlbB (holo forms) with 
the amino acids together with ATP in the presence of cysteamine allowed chemical cleavage 
of the NRPS-bound intermediates to form cystamine adducts that can be detected by LC-
HRMS (Figure 5 and Figure S28). Using this strategy, we detected cystamine-bound Val 15 
as the major product accumulated when AlbA was assayed with L-Val and ATP (Figure 5B 
and Figure S28A), confirming that Val is indeed activated by A1. In an assay of holo-AlbA and 
-AlbB with L-Val, L-Ser, and ATP, we were able to detect ions corresponding to both cystamine 
adducted Val-Ser 16 intermediate (Figure 5B and Figure S28B) and cystamine adducted Val-
aminoethylcysteine (AEC) 17 (Figure 5B and Figure S28C). 17 is generated from the non-
enzymatic product of Val-Dha in the presence of cysteamine under mild alkaline conditions[31]. 
Addition of L-Thr under the aforementioned assay allowed the identification of ions 
corresponding to cystamine adducted Val-AEC-Thr 18 and Val-AEC-Dhb 19 as well as 
cysteamine modified albopeptide 20 (Figure 5B and Figure S28D-F).  
To finally confirm the functions of individual domains of AlbB, we purified a series of truncated 
AlbB proteins, AlbB-A2-T2, AlbB-A2-T2-C2, AlbB-A2-T2-C2-A3-T3 and AlbB-A2-T2-C2-A3-T3-C3 
(Figure S29). In an assay with holo-AlbA and AlbB-A2-T2 in presence of cysteamine, only 16 
intermediate was observed, confirming that A2 domain indeed activates Ser residue and the 
C1 domain in AlbA is responsible for the first condensation between L-Val and L-Ser (Figure 
S30). Incubation of holo-AlbB-A2-T2-C2 with AlbA allowed the identification of both 16 and 17 
(Figure S30), consolidating that C2 catalyses the dehydration reaction of Ser residue. In the 
case of the assay of holo-AlbA with AlbB-A2-T2-C2-A3-T3, we observed the presence of 18 in 
our LC-MS analysis (Figure S30), indicating that A3 domain activates L-Thr and C2 domain is 
responsible for the condensation of activated Thr residue with growing Val-Dha thioester to 
generate 13. Finally, incubation of holo-AlbA and AlbB-A2-T2-C2-A3-T3-C3 provided the 
evidence of the presence of 19-20 (Figure S30), confirming that C3 domain catalyses the 
dehydration of Thr residue and the hydrolytic offload of the mature albopeptide. The last T4 
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The presence of Dha and Dhb residues can have pronounced effects on the peptides, such 
as enhanced peptide-receptor affinity, increased stabilities to degradative enzymes and 
sometimes good enzyme inhibitors by serving as electrophiles in nucleophilic addition 
reactions[32]. The contiguous Dha-(E)-Dhb residue in albopeptide 6 is structurally unique. 
Based on our in vitro pathway reconstitution and biochemical assays together with in silico 
analysis and previous knowledge25, 27, 35, we propose the biosynthetic pathway for albopeptide 
6 as depicted in Figure 5A. L-Val, L-Ser and L-Thr are activated and loaded onto T domains 
by AlbA and AlbB, respectively. The thiolated Ser is condensed with Val by C1 domain, 
followed by the dehydration, catalysed by C2, to form the dipeptide Val-Dha thioester 12. 
 
Figure 5. A. Overview of NRP assembly of 6 and in vitro capture of putative biosynthetic 
intermediates via cysteamine. B. Mass spectra of intermediates captured by cysteamine in 
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Subsequent condensation with the thiolated Thr yields the Val-Dha-Thr thioester 13, followed 
by the second dehydration event on Thr residue, by C3, to produce the last intermediate, Val-
Dha-(E)-Dhb thioester 14. Finally, C3 catalyses the hydrolysis of the T3 bound intermediate to 
afford 6 (Figure 5A). Among four chain release mechanisms have been discovered thus far in 
the NRPS assembly lines[33–35], terminal C-like domains (CT) have been found to be 
responsible for the formation of macrolactone[36,37], macrolactam[38], amides[39,40] and 
carboxylic acids[41]. Phylogenetic analysis of selected CT domains and C3 showed that C3 is 
clearly diverged from most of CT domains30-34 but is closely related to Crok-CT in the 
biosynthesis of crocacin catalysing the hydrolysis of the fully elongated intermediate[41] (Figure 
S31). Interestingly, we also observed the presence of the ion corresponding to cysteamine 
adduct albopeptide, Val-AEC-Dhb 20 (Figure 5A), demonstrating its reactivity of 6 towards the 
Michael donors. 
Taken together, our biochemical analyses provided direct evidence of the accurate timing of 
dehydration events on Ser and Thr residues in this AlbB NRPS, where the formation of Dha 
occurs following the first condensation and the formation of Dhb occurs following the second 
condensation prior hydrolysis to yield 6. 
The identification of the NRPS pathway of 6 enabled the use of comparative genomic 
approaches to identify other BGCs for the production of short dehydrated 6-like metabolites. 
Blast search in NCBI using AlbB as the sequence query allowed identification of hundreds of 
AlbB-like open reading frames (ORFs). Phylogenetic analysis of these ORFs suggested that 
one clade is closely related to AlbB (Figure S32). Using this guidance to analyse the genes 
around these orfs in NCBI, we identified a few BGCs from Gram-positive and Gram-negative 
bacteria (Figure 6; Table S4), which are potential producers of 6-like metabolites. Interestingly, 
these BGCs can be grouped into three subfamilies (Figure 6). While the first group (top box, 
Figure 6) is likely to direct the production of metabolites containing the Val-Dha-Dhb scaffold, 
the second one (middle box, Figure 6) is likely to produce metabolites containing a hydrophilic 
moiety, i.e. Glu or Asp residue, instead of Val residue in 6 in the N-terminal. Such examples 
can be found in Vibro parahaemolyticus, the leading causal agent of human acute 
gastroenteritis[42] and Dickerya fangzhongdai, plant pathogens that mostly cause soft-rot 
diseases[43]. The products of the third subgroup (bottom box, Figure 6) are unclear due to the 
limited information of A domains. The common feature of these multidomain NRPSs is that 
they all contain C* domains which are likely to possess dual functions, condensation and 
dehydration. Taken together, these BGCs are likely to direct the production of a previously 
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Many NRPs containing dhAA residues or moieties likely derived from dhAA have been 
discovered thus far, only few of which have been carried out to examine the formation of dhAA 
residues in these metabolites. Recently NocB-M5C in the nocardicin 3 biosynthesis has been 
shown to be responsible for the generation of the cryptic transient Dha species during the 
course of the β-lactam formation [7,14]. Our phylogenetic analysis suggested that NocB-M5C 
belongs to the clade of normal DCL domains[23] that catalyse the condensation reaction with D-
amino acids (Figure S33).Unlike NocB-M5C, both C2 and C3 form a clade with other C* 
domains (Figures S33). This group of C* domains possesses a typical HHxxxDG catalytic 
motif emblematic of conventional C domains and lacks the third His residue in case of 
nocardicin[14], suggesting that these C* domains are evolutionarily diverged from NocB-M5C. 
Structural modelling of C2 and C3 in Phyre2 Server[44] suggested that the overall folding of 
these two C* domains share good similarity (100% confidence, 23% identity) to one of the C 
domain (Txo2-C2) in the biosynthesis of the potent antibiotic, teixobactin, which catalyses the 
condensation reaction between the growing peptidyl thioester and L-Ser[45]. However, it was 
noticed that one loop (A382-T389 in the case of C2) in both predicted structures of C2 and C3 
appear to be in the closer proximity toward the catalytic centres of both enzymes, compared 
to Txo2-C2 (Figure S34 and S35). Protein MEME analysis[46] suggested that one Glu residue 
(E387 in the case of C2) is highly conserved among these C* domains, which is absent in other 
types of C domains, implying that this residue and its surrounding may involve the dehydration 
reaction (Figure S36). A combination of biophysics and site-directed mutagenesis will shed 
 
Figure 6. Conserved genomic context of representatives of a new group of alb-like BGCs 
identified in bacterial strains, suggesting that this previously unnoticed group of short 
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light on the dehydration mechanism of AlbB-C2 and C3 domains, which requires further 
investigation in our laboratory. 
NPs have been considered privileged structures in drug discovery. The molecular scaffolds 
(or pharmacophores) of NPs provide biologically relevant chemical space which are 
inspirations for modern antimicrobial drug discovery and development[47]. 6 displays potent 
activity against a VRE isolate. VRE is one of ESKAPE pathogens that acquires resistance 
against virtually all clinically used antibiotics[48],[49] and is assigned as a high priority pathogen 
by WHO on its global priority list of antibiotic-resistant bacteria[50]. Therefore, there is a growing 
interest in discovery of novel antibacterial agents against VRE. In this respect, 6 may offer 
alternative option for the future lead development against VRE. The mode of action of 6 
against VRE will be the focus of our future studies.  
Conclusion 
We have discovered a new short antimicrobial peptide, albopeptide 6, in the culture broth of 
S. albofacience. HR-MS and comprehensive NMR analyses, together with chemical synthesis 
of isomers, confirmed that the structure of compound 6 as L-Val-Dha-(E)-Dhb. Albopeptide 
displays potent narrow-spectrum antibacterial activity against a VRE hospital isolate with an 
MIC50 value of 2.98 µM, potentially offering a new lead to combat VRE. In vitro pathway 
reconstitution and biochemical assays combined with genomic analysis determine that 6 
originates from an unusual NRPS assembly line. This work provides evidence on the existence 
of a new group of short dehydrated NRPS peptides and exemplifies the importance of 
noncanonical NRPS biosynthetic pathways in bacterial genomes in the search for new leads. 
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